Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CNC 
Centene Corp (CNC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: CNC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
19 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $33.94
1 Year Target Price $33.94
| 7 | Strong Buy |
| 3 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -21.88% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 15.73B USD | Price to earnings Ratio 7.77 | 1Y Target Price 33.94 |
Price to earnings Ratio 7.77 | 1Y Target Price 33.94 | ||
Volume (30-day avg) 19 | Beta 0.44 | 52 Weeks Range 25.08 - 77.17 | Updated Date 09/17/2025 |
52 Weeks Range 25.08 - 77.17 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.12 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.29% | Operating Margin (TTM) -0.95% |
Management Effectiveness
Return on Assets (TTM) 2.59% | Return on Equity (TTM) 7.44% |
Valuation
Trailing PE 7.77 | Forward PE 8.96 | Enterprise Value 15914029400 | Price to Sales(TTM) 0.1 |
Enterprise Value 15914029400 | Price to Sales(TTM) 0.1 | ||
Enterprise Value to Revenue 0.09 | Enterprise Value to EBITDA 3.39 | Shares Outstanding 491133000 | Shares Floating 462347695 |
Shares Outstanding 491133000 | Shares Floating 462347695 | ||
Percent Insiders 0.46 | Percent Institutions 99.24 |
Upturn AI SWOT
Centene Corp
Company Overview
History and Background
Centene Corp. was founded in 1984 as a managed care organization. Initially focusing on government-sponsored healthcare programs, it has grown through organic expansion and acquisitions to become a major player in the industry.
Core Business Areas
- Managed Care: Provides managed healthcare services to individuals and families through government-subsidized programs, including Medicaid, Medicare, and the Health Insurance Marketplace.
- Specialty Services: Offers behavioral health, vision, dental, pharmacy benefits management, and care management services.
Leadership and Structure
Centene is led by a Chief Executive Officer (CEO) and a senior management team. The organizational structure includes various departments responsible for different aspects of the business, such as healthcare operations, finance, and strategy.
Top Products and Market Share
Key Offerings
- Medicaid Managed Care: Centene provides managed care services to Medicaid beneficiaries. It is a major player in this market, with a significant share of Medicaid enrollees in various states. Competitors include UnitedHealth Group (UNH) and Molina Healthcare (MOH).
- Medicare Advantage: Centene offers Medicare Advantage plans to seniors, providing comprehensive healthcare coverage. It competes with UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS).
- Health Insurance Marketplace: Centene sells health insurance plans through the Health Insurance Marketplace, catering to individuals and families. Competitors include Anthem (ELV) and Cigna (CI).
Market Dynamics
Industry Overview
The managed care industry is characterized by increasing demand for government-sponsored healthcare programs and a focus on cost containment and quality improvement. Regulatory changes and market consolidation are also key trends.
Positioning
Centene is a leading provider of managed care services, particularly in the government-sponsored healthcare sector. Its competitive advantages include its scale, expertise in managing complex populations, and strong relationships with government agencies.
Total Addressable Market (TAM)
The total addressable market for managed healthcare services is estimated to be in the hundreds of billions of dollars. Centene is well-positioned to capture a significant share of this market through its focus on government-sponsored programs and expansion into new markets.
Upturn SWOT Analysis
Strengths
- Large scale and market share
- Expertise in government-sponsored healthcare programs
- Strong relationships with government agencies
- Diversified product portfolio
- Established network of providers
Weaknesses
- Dependence on government funding
- Exposure to regulatory changes
- Integration challenges from acquisitions
- High debt levels
- Profit margin pressures
Opportunities
- Expansion into new markets
- Growth in government-sponsored healthcare programs
- Increasing demand for value-based care
- Technological innovation
- Acquisitions of smaller players
Threats
- Regulatory changes
- Increased competition
- Healthcare cost inflation
- Economic downturns
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- UNH
- HUM
- MOH
- CVS
- CI
- ELV
Competitive Landscape
Centene competes with other managed care organizations on price, quality, and service. Its advantages include its expertise in government-sponsored healthcare programs and its large scale. Disadvantages include dependence on government funding and exposure to regulatory changes.
Major Acquisitions
WellCare Health Plans
- Year: 2020
- Acquisition Price (USD millions): 17300
- Strategic Rationale: Expanded Centene's Medicare and Medicaid footprint and strengthened its position in government-sponsored healthcare.
Growth Trajectory and Initiatives
Historical Growth: Centene has experienced significant growth over the past years, driven by acquisitions and organic expansion.
Future Projections: Provide projections for Centene Corp's future growth based on analyst estimates.
Recent Initiatives: Highlight recent strategic initiatives undertaken by Centene Corp.
Summary
Centene is a major player in the government-sponsored healthcare market, particularly in Medicaid and Medicare. The company has grown through acquisitions and organic expansion. However, it faces challenges related to regulatory changes, healthcare cost inflation, and competition. Centene's strength lies in its scale and expertise in managing complex populations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Centene Corp.'s SEC Filings
- Company Press Releases
- Analyst Reports
- Industry Publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data and financial metrics may vary depending on the source. Investors should conduct their own research before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Centene Corp
Exchange NYSE | Headquaters Saint Louis, MO, United States | ||
IPO Launch date 2001-12-13 | CEO & Director Ms. Sarah M. London | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 60500 | Website https://www.centene.com |
Full time employees 60500 | Website https://www.centene.com | ||
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.